These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32184941)

  • 1. Early treatment efficacy of S-adenosylmethionine in patients with intrahepatic cholestasis: A systematic review.
    Noureddin M; Sander-Struckmeier S; Mato JM
    World J Hepatol; 2020 Feb; 12(2):46-63. PubMed ID: 32184941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis.
    Trauner M; Gulamhusein A; Hameed B; Caldwell S; Shiffman ML; Landis C; Eksteen B; Agarwal K; Muir A; Rushbrook S; Lu X; Xu J; Chuang JC; Billin AN; Li G; Chung C; Subramanian GM; Myers RP; Bowlus CL; Kowdley KV
    Hepatology; 2019 Sep; 70(3):788-801. PubMed ID: 30661255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study.
    Frezza M; Surrenti C; Manzillo G; Fiaccadori F; Bortolini M; Di Padova C
    Gastroenterology; 1990 Jul; 99(1):211-5. PubMed ID: 2188871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury.
    Santini D; Vincenzi B; Massacesi C; Picardi A; Gentilucci UV; Esposito V; Liuzzi G; La Cesa A; Rocci L; Marcucci F; Montesarchio V; Groeger AM; Bonsignori M; Tonini G
    Anticancer Res; 2003; 23(6D):5173-9. PubMed ID: 14981985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo-controlled study with negative results.
    Ribalta J; Reyes H; Gonzalez MC; Iglesias J; Arrese M; Poniachik J; Molina C; Segovia N
    Hepatology; 1991 Jun; 13(6):1084-9. PubMed ID: 2050326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open-label study of ademetionine for the treatment of intrahepatic cholestasis associated with alcoholic liver disease.
    Ivashkin VT; Maevskaya MV; Kobalava ZD; Uspenskiy YP; Fominih JA; Rozanov AV; Tolkacheva VV; Sotnikova TI; Alikhanov BA; Gorbacheva IA; Ershova OB; Znakhyrenko AA; Sokolov KA; Sander-Struckmeier S
    Minerva Gastroenterol Dietol; 2018 Sep; 64(3):208-219. PubMed ID: 29431335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis.
    Fickert P; Hirschfield GM; Denk G; Marschall HU; Altorjay I; Färkkilä M; Schramm C; Spengler U; Chapman R; Bergquist A; Schrumpf E; Nevens F; Trivedi P; Reiter FP; Tornai I; Halilbasic E; Greinwald R; Pröls M; Manns MP; Trauner M;
    J Hepatol; 2017 Sep; 67(3):549-558. PubMed ID: 28529147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.
    Mato JM; Cámara J; Fernández de Paz J; Caballería L; Coll S; Caballero A; García-Buey L; Beltrán J; Benita V; Caballería J; Solà R; Moreno-Otero R; Barrao F; Martín-Duce A; Correa JA; Parés A; Barrao E; García-Magaz I; Puerta JL; Moreno J; Boissard G; Ortiz P; Rodés J
    J Hepatol; 1999 Jun; 30(6):1081-9. PubMed ID: 10406187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for treating cholestasis in pregnancy.
    Burrows RF; Clavisi O; Burrows E
    Cochrane Database Syst Rev; 2001; (4):CD000493. PubMed ID: 11687082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Green Tea Extract Supplementation on Liver Enzymes in Patients with Nonalcoholic Fatty Liver Disease.
    Pezeshki A; Safi S; Feizi A; Askari G; Karami F
    Int J Prev Med; 2016; 7():28. PubMed ID: 26955458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the studies on the clinical use of S-adenosylmethionine (SAMe) for the symptomatic treatment of intrahepatic cholestasis.
    Coltorti M; Bortolini M; Di Padova C
    Methods Find Exp Clin Pharmacol; 1990; 12(1):69-78. PubMed ID: 2179653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy: a multi-centered randomized controlled trial.
    Zhang L; Liu XH; Qi HB; Li Z; Fu XD; Chen L; Shao Y
    Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3770-6. PubMed ID: 26502869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of compound Yindan decoction on alpha-naphthylisothiocyanate-Induced acute intrahepatic cholestasis in rats.
    Sun F; Li X; Xu C; Li P; Wu J; Sui J
    J Tradit Chin Med; 2019 Jun; 39(3):315-323. PubMed ID: 32186003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The results of phase III multicenter open randomized controlled study REM-Chol-III-16 in patients with intrahepatic cholestasis syndrome caused by chronic diffuse liver diseases].
    Stel'makh VV; Kovalenko AL; Popova VB; Uspenskiy YP; Morozov VG; Belikova TN; Rafalskiy VV; Antonova EA
    Ter Arkh; 2021 Dec; 93(12):1470-1476. PubMed ID: 36286675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of Cinnamomi Ramulus improving rat model of intrahepatic cholestasis induced by ANIT by regulating FXR pathway].
    Cai X; Qin RW; Liu YQ; Wang Y; Luo L; Yang F
    Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(12):2594-2599. PubMed ID: 31359729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-Adenosylmethionine Supplementation May Reduce Cancer-Related Fatigue: A Prospective Evaluation Using the FACIT-F Questionnaire in Colon Cancer Patients Undergoing Oxaliplatin-Based Chemotherapy Regimens.
    Onorato A; Napolitano A; Spoto S; Incorvaia L; Russo A; Santini D; Tonini G; Vincenzi B
    Chemotherapy; 2021; 66(5-6):161-168. PubMed ID: 34644703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Pose E; Napoleone L; Amin A; Campion D; Jimenez C; Piano S; Roux O; Uschner FE; de Wit K; Zaccherini G; Alessandria C; Angeli P; Bernardi M; Beuers U; Caraceni P; Durand F; Mookerjee RP; Trebicka J; Vargas V; Andrade RJ; Carol M; Pich J; Ferrero J; Domenech G; Llopis M; Torres F; Kamath PS; Abraldes JG; Solà E; Ginès P
    Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):31-41. PubMed ID: 31607677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of Danning tablet on acute livery injury with cholestasis induced by α-naphthylisothiocyanate in rats.
    Ding LL; Zhang BF; Dou W; Yang L; Zhan CS; Wang ZT
    J Ethnopharmacol; 2012 Mar; 140(2):222-9. PubMed ID: 22274634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Magnesium isoglycyrrhizinate prevention of chemotherapy-induced liver damage during initial treatment of patients with gastrointestinal tumors].
    Yan Y; Mo Y; Zhang D
    Zhonghua Gan Zang Bing Za Zhi; 2015 Mar; 23(3):204-8. PubMed ID: 25938834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.